With commercial insurance: PADCEV Copay Assistance Program — as little as $5 per dose, up to $25,000 per calendar year. With Medicare: the Padcev card can’t be used. HealthWell Foundation – Bladder and Urothelial Cancer - Medicare Access (enfortumab vedotin listed) is closed as of September 28, 2026.
The benefit is not valid for any other out-of-pocket costs such as medication administration charges or other healthcare provider services.
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Does not have insurance or has insurance that excludes coverage for PADCEV
Checked September 28, 2026 · Source ↗
Padcev’s card can’t be used with Medicare. These funds may help. They open and close with donations, so call before telling a Padcev patient no.
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Padcev is billed under J9177. The Padcev copay card can’t be used when Medicare or another government plan pays for Padcev (HHS OIG guidance).
Last checked September 28, 2026 against each program’s own pages (links above). Methodology →
Program details are for information only and are not a guarantee of eligibility or benefit. Confirm current terms with the program before you rely on them.